Heroin Dependence: Clinical Trials

90 trials for Heroin Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

64 completed, 16 unknown, 7 withdrawn, 3 terminated. 26 Phase 2, 22 Not applicable, 19 Phase 3, 8 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 226Completed 17, Withdrawn 7, Terminated 1, Unknown 1
Not applicable22Completed 14, Unknown 7, Terminated 1
Phase 319Completed 14, Unknown 3, Terminated 1, Withdrawn 1
Phase 18Completed 5, Unknown 2, Terminated 1
Phase 46Completed 5, Unknown 1

Follow Heroin Dependence: new trials by email Literature Review of Heroin Dependence trials Research Report on Heroin Dependence

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Light Needle for Opioid Use Disorder
Light needle therapy, Sham light needle therapy - Opioid Use Disorder
Not applicableUnknownChang Gung Memorial Hospital1002022-03-182023-05-03
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
Repetitive Transcranial Magnetic Stimulation, Sham Repetitive Transcranial Magnetic Stimulation - Opioid-use Disorder, Heroin Abuse
Not applicableCompletedUniversity of Nevada, Las Vegas242021-10-062022-05-17
Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder
Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS), Cognitive Training - Opioid-Related Disorders, Heroin Dependence
Not applicableTerminatedUniversity of Minnesota92021-01-112025-07-10
Neuroimaging and CBD for Opioid Use Disorder
Cannabidiol (CBD), Placebo - Heroin Abuse, Opioid Use Disorder
Phase 2CompletedYasmin Hurd662020-11-122025-10-27
The Effect of Self-Forgiveness on Self-Stigma in Addiction.
Six Step Model of Self-Forgiveness, Treatment as Usual (TAU) - Substance Use Disorders, Opiate Dependence
Not applicableCompletedUniversity of Pittsburgh1302019-08-012021-09-05
Youth Opioid Recovery Support: Improving Care Systems
Youth Opioid Recovery Support service model - Opioid-Related Disorders
Not applicableCompletedUniversity of Maryland, Baltimore442019-07-262022-02-07
Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin Dependence
Transcranial magnetic stimulation and Cognitive behavioral therapy - Heroin Dependence
Not applicableUnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University3002019-06-302021-03-22
PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin Addiction
Repetitive transcranial magnetic stimulation - Heroin Addiction, Relapse
Not applicableUnknownTang-Du Hospital902019-06-012021-01-22
Laser Meridian Massage in Heroin Addicts
laser meridian massage - Heroin Dependence
Not applicableUnknownChang Gung Memorial Hospital302019-02-262020-03-16
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
Buprenorphine/naloxone - Heroin Dependence
Phase 3TerminatedNew York State Psychiatric Institute82018-11-012022-12-22
Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use Disorders
Active rTMS, Sham rTMS - Transcranial Magnetic Stimulation, Heroin Dependence
Not applicableUnknownNational Cheng-Kung University Hospital602017-08-012020-09-16
Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
Extended release morphine, Buprenorphine/Naloxone low dose, Buprenorphine/Naloxone moderate dose - Heroin Dependence, Opioid Use Disorder
Phase 1 / Phase 2CompletedWayne State University262016-12-012020-11-10
Change the Cycle: An RCT to Prevent Injection Initiation
Change the Cycle - Substance Abuse, Intravenous, HIV
Not applicableCompletedUniversity of Southern California9792016-06-012023-03-20
Methadone Induced Memory Retrieval-extinction Procedure in Heroin Addicts
methadone induced memory retrieval-extinction procedure - Heroin Dependence
Not applicableCompletedNational Institute on Drug Dependence, China872015-11-202019-10-21
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Not applicable - no defined intervention - Opioid-use Disorder, Opioid-related Disorders
CompletedIndivior Inc.5342015-08-012019-04-18
Methadone Maintenance Outcome Study in Taiwan: 5-year Follow-up
Heroin Dependence, Sleep Impairment
UnknownNational Health Research Institutes, Taiwan12002015-04-012015-11-20
University of Houston Drug Abuse Research Development Program II
Virtual Reality Cue Exposure Therapy, Relapse Prevention Drug Education - Heroin Dependence
Not applicableUnknownUniversity of Houston1002014-08-012018-08-06
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
Extended-Release Naltrexone - Heroin Dependence, Opioid-Related Disorders
Phase 4CompletedNYU Langone Health2172014-06-272021-06-25
Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia
Mirtazapine, Placebo - Heroin Dependence, Amphetamine Dependence
Phase 3UnknownUniversiti Sains Malaysia802013-05-012015-09-04
An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence
paliparidone - Heroin Dependence, Amphetamine Dependence
Phase 3UnknownUniversiti Sains Malaysia402013-05-012015-09-04

Showing 20 of 90. Sign in to see all of them.

Narrower conditions

Opioid-Related Disorders (53)  ·  Substance-Related Disorders (15)  ·  Cocaine-Related Disorders (11)  ·  Behavior, Addictive (6)  ·  Substance Abuse, Intravenous (5)  ·  Amphetamine-Related Disorders (4)  ·  Morphine Dependence (3)  ·  HIV Infections (2)  ·  Recurrence (2)  ·  Substance Withdrawal Syndrome (2)  ·  Alcoholism (1)  ·  Chemically-Induced Disorders (1)  ·  Depression (1)  ·  Hepatitis C (1)

Broader conditions

Narcotic-Related Disorders (90)  ·  Chemically-Induced Disorders (89)  ·  Mental Disorders (89)  ·  Substance-Related Disorders (75)  ·  Opioid-Related Disorders (37)  ·  Behavior (8)  ·  Compulsive Behavior (6)  ·  Impulsive Behavior (6)  ·  Blood-Borne Infections (3)  ·  Communicable Diseases (3)  ·  Infections (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Disease Attributes (2)  ·  Genital Diseases (2)

Interventions

Buprenorphine (12)  ·  Naltrexone (8)  ·  Buprenorphine, Naloxone Drug Combination (7)  ·  vivitrol (6)  ·  Methadone (5)  ·  Hydromorphone (3)  ·  Transcranial Magnetic Stimulation (3)  ·  Cognitive Behavioral Therapy (2)  ·  Methadyl Acetate (2)  ·  Therapeutics (2)  ·  2-methylcyclopentadienyl manganese tricarbonyl (1)  ·  Administration, Sublingual (1)  ·  Aprepitant (1)  ·  Buspirone (1)  ·  Cannabidiol (1)

Sponsors

National Institute on Drug Abuse (NIDA) (13)  ·  New York State Psychiatric Institute (10)  ·  Wayne State University (7)  ·  Johns Hopkins University (6)  ·  University of Colorado, Denver (6)  ·  National Health Research Institutes, Taiwan (4)  ·  Friends Research Institute, Inc. (3)  ·  Universiti Sains Malaysia (3)  ·  Chang Gung Memorial Hospital (2)  ·  Karolinska University Hospital (2)  ·  L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. (2)  ·  National Institute on Drug Dependence, China (2)  ·  Shanghai Mental Health Center (2)  ·  University of California, Los Angeles (2)  ·  University of Pennsylvania (2)

Countries

United States (61)  ·  China (5)  ·  Taiwan (5)  ·  Malaysia (3)  ·  Russia (3)  ·  Sweden (3)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Switzerland (1)  ·  Vietnam (1)

Top investigators

Mark Greenwald, PhD (8)  ·  Leslie Amass, Ph.D. (6)  ·  Kenneth Silverman, Ph.D. (3)  ·  Walter Ling, M.D. (3)  ·  Edward Nunes, M.D. (2)  ·  Jack Mendelson, M.D. (2)  ·  John Rotrosen, M.D. (2)  ·  Vicknasingam Kasinather, PhD (2)  ·  Adam Bisaga, MD (1)  ·  Alexander Okhapkin, Prof. (1)  ·  Alexander Sofronov, Prof. (1)  ·  Alexey Egorov, Prof. (1)  ·  Alison Oliveto, Ph.D. (1)  ·  Alison Ritter, PhD (1)  ·  Andrey Anipchenko, Dr. (1)

Results publications

PMID 25630964, PMID 25911999, PMID 40342086, PMID 22339949, PMID 15876901, PMID 16002025, PMID 16870915, PMID 17581533, PMID 17628351, PMID 17933486, PMID 17970256, PMID 18612373, PMID 18855822, PMID 19283561, PMID 19339140, PMID 20631574, PMID 20881947, PMID 21513688, PMID 21529928, PMID 21715107, PMID 22029398, PMID 22134175, PMID 22233189, PMID 22545737, PMID 22882399, PMID 22945623, PMID 23036218, PMID 23161001, PMID 23205722, PMID 23572466, PMID 23701526, PMID 23874575, PMID 24239030, PMID 24813900, PMID 24875677, PMID 25124257, PMID 25134047, PMID 25556837, PMID 25580067, PMID 25619263, PMID 25901451, PMID 26107818, PMID 26331953, PMID 26792095, PMID 27049826, PMID 27178765, PMID 27436632, PMID 27620325, PMID 28526048, PMID 29471930

NIH funding

R01DA011160 (6), R01DA015462 (4), R01DA010746 (3), K23DA020000 (2), R01DA022243 (2), 1UG3DA048508-01 (1), K01DA022398 (1), K23DA021512 (1), P50DA009236 (1), R01DA009803 (1), R01DA012564 (1), R01DA013636 (1), R01DA015822 (1), R01DA016237 (1), R01DA017317 (1)